Skip to main content

FGFR Gene Alteration clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the efficacy and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatment of participants with unresectable or metastatic cholangiocarcinoma with FGFR2 rearrangement.

    Orange, California and other locations

Last updated: